210 related articles for article (PubMed ID: 19240773)
1. [Risk of urolithiasis in patients with cystic fibrosis].
Campuzano S; Díaz JJ; Bousoño C; Rodríguez M; Campos C; Málaga S
Nefrologia; 2009; 29(1):61-6. PubMed ID: 19240773
[TBL] [Abstract][Full Text] [Related]
2. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
4. Is there a risk for kidney stone formation in cystic fibrosis?
Böhles H; Michalk D
Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis.
Böhles H; Gebhardt B; Beeg T; Sewell AC; Solem E; Posselt G
J Pediatr; 2002 Jan; 140(1):103-9. PubMed ID: 11815772
[TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
Dobson L; Stride A; Bingham C; Elworthy S; Sheldon CD; Hattersley AT
Pediatr Pulmonol; 2005 Feb; 39(2):103-7. PubMed ID: 15573388
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population.
Watts KD; Seshadri R; Sullivan C; McColley SA
Pediatr Pulmonol; 2009 Jun; 44(6):594-601. PubMed ID: 19437506
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for small bowel bacterial overgrowth in cystic fibrosis.
Fridge JL; Conrad C; Gerson L; Castillo RO; Cox K
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):212-8. PubMed ID: 17255834
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis and calcium oxalate nephrolithiasis.
Chidekel AS; Dolan TF
Yale J Biol Med; 1996; 69(4):317-21. PubMed ID: 9273985
[TBL] [Abstract][Full Text] [Related]
11. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.
Fluge G; Olesen HV; Gilljam M; Meyer P; Pressler T; Storrösten OT; Karpati F; Hjelte L
J Cyst Fibros; 2009 May; 8(3):198-202. PubMed ID: 19303374
[TBL] [Abstract][Full Text] [Related]
12. Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.
Lucidi V; Alghisi F; Raia V; Russo B; Valmarana L; Valmarana R; Coruzzo A; Beschi S; Dester S; Rinaldi D; Maglieri M; Guidotti ML; Ravaioli E; Pesola M; De Alessandri A; Padoan R; Grynzich L; Ratclif L; Repetto T; Ambroni M; Provenzano E; Tozzi AE; Colombo C
J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):335-42. PubMed ID: 19543116
[TBL] [Abstract][Full Text] [Related]
13. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
[TBL] [Abstract][Full Text] [Related]
14. [MRI-based flow measurements in the main pulmonary artery to detect pulmonary arterial hypertension in patients with cystic fibrosis].
Wolf T; Anjorin A; Posselt H; Smaczny C; Vogl TJ; Abolmaali N
Rofo; 2009 Feb; 181(2):139-46. PubMed ID: 19101881
[TBL] [Abstract][Full Text] [Related]
15. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.
Rovner AJ; Zemel BS; Leonard MB; Schall JI; Stallings VA
J Pediatr; 2005 Sep; 147(3):327-31. PubMed ID: 16182670
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
17. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations.
Newport S; Amin N; Dozor AJ
Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404
[TBL] [Abstract][Full Text] [Related]
19. Expressions of hope in cystic fibrosis patients: a comparison with the general population.
Rustøen T; Wahl AK; Hanestad BR; Gjengedal E; Moum T
Heart Lung; 2004; 33(2):111-8. PubMed ID: 15024376
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients.
Al-Aloul M; Jackson M; Bell G; Ledson M; Walshaw M
J Cyst Fibros; 2007 Jan; 6(1):41-7. PubMed ID: 16807143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
